Blueprint Medicines Corp. is a company in the U.S. stock market and it is a holding in 47 U.S.-traded ETFs. BPMC has around 3.4M shares in the U.S. ETF market. The largest ETF holder of BPMC is the SPDR S&P Biotech ETF (XBI), with approximately 783.71K shares. Investors may also find of interest that the ETF with the largest allocation to BPMC stock is Global X Genomics & Biotechnology ETF (GNOM), with a portfolio weight of 3.11%. On average, U.S. ETFs allocate 0.28% of BPMC to their portfolios.
Additionally, BPMC is a favorite stock for Vanilla and Growth ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with BPMC as a holding is the Virtus LifeSci Biotech Clinical Trials ETF (BBC), with a return of 27.53%.